[HTML][HTML] Anti-fungal efficacy and mechanisms of flavonoids

MS Al Aboody, S Mickymaray - Antibiotics, 2020 - mdpi.com
The prevalence of fungal infections is growing at an alarming pace and the pathogenesis is
still not clearly understood. Recurrence of these fungal diseases is often due to their …

[HTML][HTML] Pathogenic drug resistant fungi: a review of mitigation strategies

M Garvey, NJ Rowan - International Journal of Molecular Sciences, 2023 - mdpi.com
Fungal pathogens cause significant human morbidity and mortality globally, where there is a
propensity to infect vulnerable people such as the immunocompromised ones. There is …

Recent trends in the epidemiology of fungal infections

EE Seagle, SL Williams, TM Chiller - Infectious Disease Clinics, 2021 - id.theclinics.com
Discussion The epidemiology of fungal diseases is constantly evolving. Environmental
changes, medical advancements, emerging species, and diagnostic and therapeutic …

Cryptococcal meningoencephalitis: time for action

KE Stott, A Loyse, JN Jarvis, M Alufandika… - The Lancet Infectious …, 2021 - thelancet.com
Cryptococcal meningoencephalitis was first described over a century ago. This fungal
infection is preventable and treatable yet continues to be associated with excessive …

[HTML][HTML] What's New in Cryptococcus gattii: From Bench to Bedside and Beyond

J Beardsley, A Dao, C Keighley, K Garnham… - Journal of Fungi, 2022 - mdpi.com
Cryptococcus species are a major cause of life-threatening infections in
immunocompromised and immunocompetent hosts. While most disease is caused by …

[HTML][HTML] Museal indoor air quality and public health: an integrated approach for exhibits preservation and ensuring human health

DC Ilieș, B Safarov, T Caciora, A Ilieș, V Grama, G Ilies… - Sustainability, 2022 - mdpi.com
The quality of the indoor microclimate in museums is a problem of great interest to the
contemporary society, given that it is in close connection with the health and comfort of …

[HTML][HTML] Synergistic and antagonistic drug interactions in the treatment of systemic fungal infections

MA Wambaugh, ST Denham, M Ayala, B Brammer… - Elife, 2020 - elifesciences.org
Invasive fungal infections cause 1.6 million deaths annually, primarily in
immunocompromised individuals. Mortality rates are as high as 90% due to limited …

[HTML][HTML] Dormancy in Cryptococcus neoformans: 60 years of accumulating evidence

A Alanio - The Journal of clinical investigation, 2020 - Am Soc Clin Investig
Cryptococcus neoformans is an opportunistic yeast that is present worldwide and interacts
with various organisms. In humans, it is responsible for cryptococcosis, a deadly invasive …

[HTML][HTML] Dangerous Liaisons: Interactions of Cryptococcus neoformans with Host Phagocytes

EA Gaylord, HL Choy, TL Doering - Pathogens, 2020 - mdpi.com
Cryptococcus neoformans is an opportunistic fungal pathogen and a leading cause of death
in immunocompromised individuals. The interactions of this yeast with host phagocytes are …

[HTML][HTML] Fungal CNS infections in Africa: the neuroimmunology of cryptococcal meningitis

SH Mohamed, TK Nyazika, K Ssebambulidde… - Frontiers in …, 2022 - frontiersin.org
Cryptococcal meningitis (CM) is the leading cause of central nervous system (CNS) fungal
infections in humans, with the majority of cases reported from the African continent. This is …